30,291 Shares in Addus HomeCare Corporation $ADUS Purchased by Dean Capital Management

Dean Capital Management acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 30,291 shares of the company’s stock, valued at approximately $2,837,000. Addus HomeCare accounts for 1.2% of Dean Capital Management’s portfolio, making the stock its 20th largest holding.

Several other institutional investors have also added to or reduced their stakes in the business. Capital Research Global Investors increased its stake in shares of Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares in the last quarter. Freestone Grove Partners LP raised its holdings in Addus HomeCare by 5,035.2% during the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after acquiring an additional 135,246 shares during the period. Dimensional Fund Advisors LP raised its holdings in Addus HomeCare by 11.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock valued at $69,689,000 after acquiring an additional 78,415 shares during the period. Empowered Funds LLC boosted its holdings in shares of Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after acquiring an additional 46,137 shares during the period. Finally, Adage Capital Partners GP L.L.C. bought a new position in shares of Addus HomeCare in the second quarter worth $4,838,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $114.55 on Monday. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $124.43. The stock has a fifty day moving average of $99.25 and a 200 day moving average of $101.20. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of 21.17, a P/E/G ratio of 1.57 and a beta of 0.88.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The business had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same period in the prior year, the company earned $1.42 EPS. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, research analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 788 shares of company stock worth $73,506 over the last ninety days. 4.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ADUS. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Barclays lifted their target price on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. Finally, Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.50.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.